Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
The LEAP trial randomized 640 infants, aged 4 to 11 months with severe eczema, egg allergy, or both, to early peanut introduction or avoidance during early life. These participants encompassed the LEAP screening study groups II and III; each of these 2 cohorts was independently powered, randomized, and analyzed.7 The LEAP trial determined that peanut allergy was prevented in the early introduction group within both cohorts (Table E2).7,17
Copyright and License information: ©2023 The Authors
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
